Table of Contents Author Guidelines Submit a Manuscript
Rehabilitation Research and Practice
Volume 2014, Article ID 873872, 16 pages
http://dx.doi.org/10.1155/2014/873872
Research Article

Assessing Function and Endurance in Adults with Spinal and Bulbar Muscular Atrophy: Validity of the Adult Myopathy Assessment Tool

1Research Service/Geriatrics and Extended Care, Washington, DC Veterans Affairs Medical Center, 50 Irving Street, NW, Room 11G, Washington, DC 20422, USA
2School of Public Health and Health Services, George Washington University, 2033 K Street, NW, Suite 210, Washington, DC 20006, USA
3Rehabilitation Medicine Department, Clinical Center, Department of Health and Human Services (DHHS), National Institutes of Health (NIH), 10 Center Drive, Bethesda, MD 20892, USA
4National Institute of Neurological Disorders and Stroke (NINDS), Neurogenetics Branch, Department of Health and Human Services (DHHS), National Institutes of Health (NIH), Building 35, Room 2A-1000, 35 Convent Drive, MSC 3705, Bethesda, MD 20892, USA
5Department of Epidemiology, University of North Carolina at Chapel Hill Gillings, School of Global Public Health, 170 Rosenau Hall, Campus Box 7400, 135 Dauer Drive, Chapel Hill, NC 27599, USA
6Center for Patient Care and Outcomes Research, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA
7Clinical Neurosciences Program, NINDS, NIH, 10 Center Drive, Room 5N230, Bethesda, MD 20814, USA
8Neurology Department, University of Maryland, 110 South Paca Street, Baltimore, MD 21201, USA
9Physical Medicine and Rehabilitation Service, Veterans Affairs Medical Center, 650 East Indian School Road, Phoenix AZ 85012, USA
10Department of Physical Therapy, Thomas J. Long School of Pharmacy & Health Sciences, University of the Pacific, 3601 Pacific Avenue, Stockton, CA 95211, USA

Received 9 February 2014; Accepted 7 April 2014; Published 5 May 2014

Academic Editor: Jeffrey Jutai

Copyright © 2014 Michael O. Harris-Love et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Mänty, C. F. de Leon, T. Rantanen et al., “Mobility-related fatigue, walking speed, and muscle strength in older people,” The Journals of Gerontology A, Biological Sciences and Medical Sciences, vol. 67, no. 5, pp. 523–529, 2012. View at Google Scholar
  2. T. Rantanen, J. M. Guralnik, S. Leveille et al., “Racial differences in muscle strength in disabled older women,” Journals of Gerontology A, Biological Sciences and Medical Sciences, vol. 53, no. 5, pp. B355–B361, 1998. View at Google Scholar · View at Scopus
  3. T. Rantanen, “Muscle strength, disability and mortality,” Scandinavian Journal of Medicine and Science in Sports, vol. 13, no. 1, pp. 3–8, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. L. P. Lowes, L. Alfano, L. Viollet et al., “Knee extensor strength exhibits potential to predict function in sporadic inclusion-body myositis,” Muscle and Nerve, vol. 45, no. 2, pp. 163–168, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. B. H. Jacobson, D. Smith, J. Fronterhouse, C. Kline, and A. Boolani, “Assessment of the benefit of powered exercises for muscular endurance and functional capacity in elderly participants,” Journal of Physical Activity & Health, vol. 9, no. 7, pp. 1030–1035, 2012. View at Google Scholar
  6. M. O. Harris-Love, “Physical activity and disablement in the idiopathic inflammatory myopathies,” Current Opinion in Rheumatology, vol. 15, no. 6, pp. 679–690, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. Huber, J. E. Hicks, P. A. Lachenbruch et al., “Validation of the childhood health assessment questionnaire in the juvenile idiopathic myopathies,” Journal of Rheumatology, vol. 28, no. 5, pp. 1106–1111, 2001. View at Google Scholar · View at Scopus
  8. U. Svantesson, U. Österberg, R. Thomeé, and G. Grimby, “Muscle fatigue in a standing heel-rise test,” Scandinavian Journal of Rehabilitation Medicine, vol. 30, no. 2, pp. 67–72, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. R. T. Moxley III, “Evaluation of neuromuscular function in inflammatory myopathy,” Rheumatic Disease Clinics of North America, vol. 20, no. 4, pp. 827–843, 1994. View at Google Scholar · View at Scopus
  10. A. Josefson, E. Romanus, and J. Carlsson, “A functional index in myositis,” Journal of Rheumatology, vol. 23, no. 8, pp. 1380–1384, 1996. View at Google Scholar · View at Scopus
  11. J. M. Guralnik, “Assessment of physical performance and disability in older persons,” Muscle and Nerve, vol. 20, no. 5, pp. S14–S16, 1997. View at Google Scholar · View at Scopus
  12. M. H. Brooke, G. M. Fenichel, R. C. Griggs et al., “Clinical investigation in Duchenne dystrophy: II. Determination of the “power” of therapeutic trials based on the natural history,” Muscle and Nerve, vol. 6, no. 2, pp. 91–103, 1983. View at Google Scholar · View at Scopus
  13. C. M. McDonald, R. T. Abresch, G. T. Carter et al., “Profiles of neuromuscular diseases. Duchenne muscular dystrophy,” American Journal of Physical Medicine & Rehabilitation, vol. 74, no. 5, supplement, pp. S70–S92, 1995. View at Google Scholar · View at Scopus
  14. E. N. Brandt and A. M. Pope, Enabling America: Assessing the Role of Rehabilitation Science and Engineering, National Academy Press, Washington, DC, USA, 1997.
  15. World Health Organization, International Classification of Functioning, Disability and Health (ICF), Geneva, Switzerland, 2001.
  16. C. A. McHorney and A. R. Tarlov, “Individual-patient monitoring in clinical practice: are available health status surveys adequate?” Quality of Life Research, vol. 4, no. 4, pp. 293–307, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. M. O. Harris-Love, G. Joe, and D. E. Koziol, “Performance-based assessment of functional limitation and muscle endurance: reliability of the Adult Myositis Assessment Tool,” Journal of Neurologic Physical Therapy, vol. 28, no. 4, pp. 179–180, 2004. View at Google Scholar
  18. A. R. La Spada, E. M. Wilson, D. B. Lubahn, A. E. Harding, and K. H. Fischbeck, “Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy,” Nature, vol. 352, no. 6330, pp. 77–79, 1991. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Chahin, C. Klein, J. Mandrekar, and E. Sorenson, “Natural history of spinal-bulbar muscular atrophy,” Neurology, vol. 70, no. 21, pp. 1967–1971, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. A. Ferrante and A. J. Wilbourn, “The characteristic electrodiagnostic features of Kennedy’s disease,” Muscle Nerve, vol. 20, no. 3, pp. 323–329, 1997. View at Google Scholar
  21. L. E. Rhodes, B. K. Freeman, S. Auh et al., “Clinical features of spinal and bulbar muscular atrophy,” Brain, vol. 132, no. 12, pp. 3242–3251, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. The National Isometric Muscle Strength (NIMS) Database Consortium, “Muscular weakness assessment: use of normal isometric strength data,” Archives of Physical Medicine and Rehabilitation, vol. 77, no. 12, pp. 1251–1255, 1996. View at Google Scholar · View at Scopus
  23. A. W. Andrews, M. W. Thomas, and R. W. Bohannon, “Normative values for isometric muscle force measurements obtained with hand-held dynamometers,” Physical Therapy, vol. 76, no. 3, pp. 248–259, 1996. View at Google Scholar · View at Scopus
  24. J. P. R. Selman, A. A. de Camargo, J. Santos, F. C. Lanza, and S. Dal Corso, “Reference equation for the two-minute walk test in adults and the elderly,” Respiratory Care, vol. 59, no. 4, pp. 525–530, 2014. View at Google Scholar
  25. H. Banno, M. Katsurio, K. Suzuki et al., “Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy,” Annals of Neurology, vol. 65, no. 2, pp. 140–150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Goverover, A. R. O'Brien, N. B. Moore, and J. DeLuca, “Actual reality: a new approach to functional assessment in persons with multiple sclerosis,” Archives of Physical Medicine and Rehabilitation, vol. 91, no. 2, pp. 252–260, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. R. J. Shephard, “Limits to the measurement of habitual physical activity by questionnaires,” British Journal of Sports Medicine, vol. 37, no. 3, pp. 197–206, 2003. View at Google Scholar · View at Scopus
  28. S. F. E. van Weely, J. C. van Denderen, M. P. M. Steultjens et al., “Moving instead of asking? Performance-based tests and BASFI-questionnaire measure different aspects of physical function in ankylosing spondylitis,” Arthritis Research and Therapy, vol. 14, no. 2, article R52, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. L. E. Fernández-Rhodes, A. D. Kokkinis, M. J. White et al., “Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial,” The Lancet Neurology, vol. 10, no. 2, pp. 140–147, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Rossier and D. T. Wade, “Validity and reliability comparison of 4 mobility measures in patients presenting with neurologic impairment,” Archives of Physical Medicine and Rehabilitation, vol. 82, no. 1, pp. 9–13, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. J. M. Stolwijk-Swüste, A. Beelen, G. J. Lankhorst et al., “SF36 physical functioning scale and 2-minute walk test advocated as core qualifiers to evaluate physical functioning in patients with late-onset sequelae of poliomyelitis,” Journal of Rehabilitation Medicine, vol. 40, no. 5, pp. 387–394, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. K. E. Light, A. L. Bebrman, M. Thigpen, and W. J. Triggs, “The 2-minute walk test: a tool for evaluating walking endurance in clients with Parkinson’s disease,” Journal of Neurologic Physical Therapy, vol. 21, no. 4, pp. 136–139, 1997. View at Google Scholar
  33. R. J. Butland, J. Pang, E. R. Gross, A. A. Woodcock, and D. M. Geddes, “Two-, six-, and 12-minute walking tests in respiratory disease,” British Medical Journal, vol. 284, no. 6329, pp. 1607–1608, 1982. View at Google Scholar · View at Scopus
  34. S. H. Subramony, W. May, D. Lynch et al., “Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale,” Neurology, vol. 64, no. 7, pp. 1261–1262, 2005. View at Google Scholar · View at Scopus
  35. D. R. Lynch, J. M. Farmer, A. Y. Tsou et al., “Measuring Friedreich ataxia: complementary features of examination and performance measures,” Neurology, vol. 66, no. 11, pp. 1711–1716, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Riazi, J. C. Hobart, D. L. Lamping et al., “Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles,” Journal of Neurology Neurosurgery and Psychiatry, vol. 74, no. 6, pp. 710–714, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Finas, M. Bals-Pratsch, J. Sandmann et al., “Quality of life in elderly men with androgen deficiency,” Andrologia, vol. 38, no. 2, pp. 48–53, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. J. E. Ware, M. Kosinski, J. B. Bjorner, D. M. Turner-Bowker, B. Gandek, and M. E. Maruish, User’s Manual for the SF-36v2 Health Survey, QualtiyMetric, Lincoln, Mass, USA, 2nd edition, 2007.
  39. J. E. Ware, M. Kosinski, and J. E. Dewey, How to Score Version Two of the SF-36—Health Survey, QualityMetric, Lincoln, Mass, USA, 2000.
  40. L. G. Portney and M. P. Watkins, Foundations of Clinical Research: Applications to Practice, Pearson/Prentice Hall, Upper Saddle River, NJ, USA, 2009.
  41. S. L. Foster and J. D. Cone, “Validity issues in clinical assessment,” Psychological Assessment, vol. 7, no. 3, pp. 248–260, 1995. View at Publisher · View at Google Scholar · View at Scopus
  42. B. H. Munro, Statistical Methods for Health Care Research, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 4th edition, 2001.
  43. A. Field, Discovering Statistics Using SPSS, Sage, Los Angeles, Calif, USA, 2009.
  44. S. Jaric, “Role of body size in the relation between muscle strength and movement performance,” Exercise and Sport Sciences Reviews, vol. 31, no. 1, pp. 8–12, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Jaric, “Muscle strength testing: use of normalisation for body size,” Sports Medicine, vol. 32, no. 10, pp. 615–631, 2002. View at Google Scholar · View at Scopus
  46. M. Brown, “Skeletal muscle and bone: effect of sex steroids and aging,” American Journal of Physiology—Advances in Physiology Education, vol. 32, no. 2, pp. 120–126, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Rantanen, J. M. Guralnik, G. Izmirlian et al., “Association of muscle strength with maximum walking speed in disabled older women,” American Journal of Physical Medicine and Rehabilitation, vol. 77, no. 4, pp. 299–305, 1998. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Doyu, G. Sobue, E. Mukai et al., “Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene,” Annals of Neurology, vol. 32, no. 5, pp. 707–710, 1992. View at Publisher · View at Google Scholar · View at Scopus
  49. A. R. La Spada, D. B. Roling, A. E. Harding et al., “Meiotic stability and genotype—phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy,” Nature Genetics, vol. 2, no. 4, pp. 301–304, 1992. View at Google Scholar · View at Scopus
  50. N. Atsuta, H. Watanabe, M. Ito et al., “Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients,” Brain, vol. 129, no. 6, pp. 1446–1455, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Alexanderson, L. Broman, A. Tollbäck, A. Josefson, I. E. Lundberg, and C. H. Stenström, “Functional Index-2: validity and reliability of a disease-specific measure of impairment in patients with polymyositis and dermatomyositis,” Arthritis Care and Research, vol. 55, no. 1, pp. 114–122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. R. L. Lieber, Skeletal Muscle Structure, Function, and Plasticity: the Physiological Basis of Rehabilitation, Lippincott Williams & Wilkins, Baltimore, Md, USA, 2010.
  53. M. O. Harris-Love, J. A. Shrader, T. E. Davenport et al., “Are repeated single-limb heel raises and manual muscle testing associated with peak plantar-flexor force in people with inclusion body myositis?” Physical Therapy, vol. 94, no. 4, pp. 543–552, 2014. View at Google Scholar
  54. J. G. Boyer, A. Ferrier, and R. Kothary, “More than a bystander: the contributions of intrinsic skeletal muscle defects in motor neuron diseases,” Frontiers in Physiology, 2013. View at Publisher · View at Google Scholar
  55. N. Chahin and E. J. Sorenson, “Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis,” Muscle and Nerve, vol. 40, no. 1, pp. 126–129, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. G. J. Salem, M.-Y. Wang, J. T. Young, M. Marion, and G. A. Greendale, “Knee strength and lower- and higher-intensity functional performance in older adults,” Medicine and Science in Sports and Exercise, vol. 32, no. 10, pp. 1679–1684, 2000. View at Google Scholar · View at Scopus
  57. L. Merlini, E. Bertini, C. Minetti et al., “Motor function-muscle strength relationship in spinal muscular atrophy,” Muscle and Nerve, vol. 29, no. 4, pp. 548–552, 2004. View at Publisher · View at Google Scholar · View at Scopus